The human macrophage cell line U937 as an in vitro model for selective evaluation of mycobacterial antigen-specific cytotoxic T-cell function.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 1783164)

Published in Immunology on February 01, 2001

Authors

J S Passmore1, P T Lukey, S R Ress

Author Affiliations

1: Clinical Immunology Laboratory, Department of Medicine, University of Cape Town & Groote Schuur Hospital, Cape Town, South Africa.

Articles citing this

Circulating gamma delta T cells in response to Salmonella enterica serovar enteritidis exposure in chickens. Infect Immun (2006) 0.95

Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody. Br J Pharmacol (2013) 0.87

C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice. J Clin Invest (2012) 0.83

Long-term maintenance of a microfluidic 3D human liver sinusoid. Biotechnol Bioeng (2015) 0.83

Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line. Clin Immunol (2013) 0.82

Chlamydia trachomatis-specific human CD8+ T cells show two patterns of antigen recognition. Infect Immun (2004) 0.81

Granule-dependent cytolysis of Mycobacterium tuberculosis-infected macrophages by human gammadelta+ T cells has no effect on intracellular mycobacterial viability. Clin Exp Immunol (2001) 0.80

Identifying putative Mycobacterium tuberculosis Rv2004c protein sequences that bind specifically to U937 macrophages and A549 epithelial cells. Protein Sci (2005) 0.80

Identification and characterization of PKF118-310 as a KDM4A inhibitor. Epigenetics (2016) 0.77

Synergistic Antimycobacterial Actions of Knowltonia vesicatoria (L.f) Sims. Evid Based Complement Alternat Med (2012) 0.75

Effect of Bee Venom and Its Fractions on the Release of Pro-Inflammatory Cytokines in PMA-Differentiated U937 Cells Co-Stimulated with LPS. Vaccines (Basel) (2016) 0.75

Effects of mesenchymal stem cell and fibroblast coating on immunogenic potential of prosthetic meshes in vitro. Surg Endosc (2014) 0.75

Articles cited by this

Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer (1976) 14.08

Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell (1988) 8.01

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1992) 7.74

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature (1993) 4.19

Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1998) 3.59

Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J Immunol (1998) 3.36

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A (1993) 3.27

Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity (1995) 3.12

Mycobacteria-reactive Lyt-2+ T cell lines. Eur J Immunol (1988) 2.88

Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med (1999) 2.42

Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24

Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med (1995) 2.24

CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor. J Immunol (1993) 2.19

Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J Exp Med (1998) 2.06

Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc Natl Acad Sci U S A (1999) 1.84

Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1996) 1.76

CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. J Immunol (1995) 1.62

CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages. J Immunol (2000) 1.61

Characterization of human Mycobacterium bovis bacille Calmette-Guérin-reactive CD8+ T cells. Infect Immun (1999) 1.60

Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology (1996) 1.54

CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J Immunol (1998) 1.52

Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J Immunol (1997) 1.50

Induced expression of the Legionella pneumophila gene encoding a 20-kilodalton protein during intracellular infection. Infect Immun (1998) 1.39

Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J Immunol (1999) 1.34

In vitro induction of cytologic and functional differentiation of the immature human monocytelike cell line U-937 with phorbol myristate acetate. Am J Pathol (1985) 1.34

Specificity of proliferative response of human CD8 clones to mycobacterial antigens. Eur J Immunol (1988) 1.23

Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen. J Exp Med (2000) 1.09

Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur J Immunol (1990) 1.07

Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am Rev Respir Dis (1992) 1.07

Expression of HLA-DR by a human monocyte cell line is under transcriptional control. J Mol Cell Immunol (1984) 0.98

Synergistic effect of retinoic acid and 1,25-dihydroxyvitamin D3 on the differentiation of the human monocytic cell line U937. Leuk Res (1991) 0.90

Production of TNF alpha and interleukin 6 by differentiated U937 cells infected with Leishmania major. New Microbiol (1997) 0.81

Differentiation-linked activation of the respiratory burst in a monocytic cell line (U937) via Fc gamma RII. A study of activation pathways and their regulation. J Immunol (1991) 0.80

Reduced natural killer cell activity in multi-drug resistant pulmonary tuberculosis. Scand J Immunol Suppl (1992) 0.80

Infection of differentiated U937 cells by Salmonella typhimurium: absence of correlation between oxidative burst and antimicrobial defence. FEMS Immunol Med Microbiol (1993) 0.77

Major histocompatibility complex class I presentation of exogenous and endogenous protein-derived peptides by a transfected human monocyte cell line. Immunology (1995) 0.77

Articles by these authors

Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients. Int J Tuberc Lung Dis (2010) 2.00

Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J Immunol (2000) 1.58

Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy. Clin Exp Immunol (2006) 1.21

In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas. Infect Immun (2000) 1.19

Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders. Clin Exp Immunol (2006) 1.09

Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am Rev Respir Dis (1992) 1.07

An in-vitro comparison of the intraphagocytic bioactivity of erythromycin and roxithromycin. J Antimicrob Chemother (1987) 1.03

HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis. J Infect Dis (2001) 1.01

Reduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosis. Clin Exp Immunol (1994) 0.99

Exposure of cord blood to Mycobacterium bovis BCG induces an innate response but not a T-cell cytokine response. Clin Vaccine Immunol (2008) 0.97

Monocyte-derived macrophage cytokine responses induced by M. bovis BCG. Tuber Lung Dis (2000) 0.91

HLA-DR expression on cytotoxic T lymphocytes. Scand J Immunol (1985) 0.87

Memory lymphocytes from tuberculous effusions: purified protein derivative (PPD) stimulates accelerated activation marker expression and cell cycle progression. Clin Exp Immunol (1996) 0.83

Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy. Cytokines Mol Ther (1995) 0.81

Reduced natural killer cell activity in multi-drug resistant pulmonary tuberculosis. Scand J Immunol Suppl (1992) 0.80

Granule-dependent cytolysis of Mycobacterium tuberculosis-infected macrophages by human gammadelta+ T cells has no effect on intracellular mycobacterial viability. Clin Exp Immunol (2001) 0.80

Dithranol mediates pro-oxidative inhibition of polymorphonuclear leukocyte migration and lymphocyte proliferation. Br J Dermatol (1987) 0.80

Cellular immunity in tuberculous pleural effusions: evidence of spontaneous lymphocyte proliferation and antigen-specific accelerated responses to purified protein derivative (PPD). Clin Exp Immunol (1992) 0.79

Benoxaprofen: a pro-oxidant anti-inflammatory drug? Agents Actions (1984) 0.78

Compartmentalization of the cellular immune response to the recombinant 65 kDa protein of Mycobacterium bovis BCG in patients with tuberculous pleuritis. Reg Immunol (1992) 0.78

A biological role for ascorbate in the selective neutralization of extracellular phagocyte-derived oxidants. Ann N Y Acad Sci (1987) 0.77

Common variable hypogammaglobulinemia. A case report. J Clin Gastroenterol (1990) 0.77

Defective polymorphonuclear leukocyte migration in AIDS. S Afr Med J (1985) 0.77

Laboratory assessment of immune status: uses and limitations. Br J Clin Pract (1986) 0.77

Basic fibroblast growth factor antagonizes transforming growth factor beta-mediated erythroid differentiation in K562 cells. Blood (1994) 0.76

Kinetics of purified protein derivative (PPD) proliferation reflects underlying suppressor mechanisms revealed by limiting dilution analysis (LDA) in patients with extrapulmonary tuberculosis (TB). Clin Exp Immunol (1998) 0.75

Ascorbate and cysteine-mediated selective neutralisation of extracellular oxidants during N-formyl peptide activation of human phagocytes. Agents Actions (1987) 0.75

The phenotype of antigen-specific suppressor T cells generated in human mixed leucocyte culture depends on the nature of the major histocompatibility regions recognized. Hum Immunol (1984) 0.75

Prostanoid modulation of synovial antigen-specific CD4+ T-cell cytotoxic function in rheumatoid arthritis. Br J Rheumatol (1995) 0.75

Polymorphonuclear leucocyte function, juvenile periodontitis and bacterial infections. S Afr Med J (1985) 0.75

Effects of benoxaprofen on the binding to and inactivation of leucoattractants by human polymorphonuclear leucocytes in vitro. Agents Actions (1985) 0.75

HLA DQ beta restriction fragment length polymorphism and rheumatoid arthritis. Association between DQw7 and rheumatoid arthritis in DR4-positive subjects. S Afr Med J (1991) 0.75

Identification of novel immunogenic Mycobacterium tuberculosis peptides that stimulate mononuclear cells from immune donors. FEMS Microbiol Lett (1999) 0.75